OPTHEA - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 79210373
Serial Number
79210373
Registration Number
5477686
Word Mark
OPTHEA
Status
700 - Registered
Status Date
2018-05-29
Filing Date
2016-12-07
Registration Number
5477686
Registration Date
2018-05-29
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2018-03-13
Attorney Name
Law Office Assigned Location Code
L70
Employee Name
THOMAS, JULIE
Statements
Goods and Services
Biological preparations for pharmaceutical purposes for the treatment of ophthalmic conditions; Chemical preparations for pharmaceutical purposes for the treatment of ophthalmic conditions; Chemical products, namely, sugars, proteins and nucleic acids for pharmaceutical use for the treatment of ophthalmic conditions; Chemicals for pharmaceutical use for the treatment of ophthalmic conditions; Pharmaceutical compositions for the treatment of ophthalmic conditions; Pharmaceutical creams for the treatment of ophthalmic conditions; Pharmaceutical drugs for the treatment of ophthalmic conditions; Pharmaceutical preparations for the treatment of ophthalmic conditions; Pharmaceutical preparations for animals for the treatment of ophthalmic conditions; Pharmaceutical preparations for human use for the treatment of ophthalmic conditions; Pharmaceutical preparations for personal use for the treatment of ophthalmic conditions; Pharmaceutical preparations for veterinary use for the treatment of ophthalmic conditions; Pharmaceutical products for the treatment of ophthalmic conditions; Pharmaceutical products for use by humans for the treatment of ophthalmic conditions; Pharmaceutical substances for the treatment of ophthalmic conditions; Veterinary medicaments for the treatment of ophthalmic conditions; Veterinary preparations for the treatment of ophthalmic conditions; Veterinary products for the treatment of ophthalmic conditions; Biological preparations for medical purposes for the treatment of ophthalmic conditions; Biological preparations for use in biotechnology for the treatment of ophthalmic conditions; Biological preparations for use in cell cultures, namely in culture media for cultivating human, animal, plant or microorganism cells for medical use; Biological preparations for veterinary purposes for the treatment of ophthalmic conditions; Biological products for medical use, namely for the treatment of ophthalmic conditions; Biological reagents for use in molecular biology for medical use; Biological substances for medical use, namely, biologics, antibodies, monoclonal antibodies, cells and cellular tissues for medical use, namely for the treatment of ophthalmic conditions; Biological tissue cultures for medical purposes; Biological tissue cultures for veterinary purposes; Chemical products, namely, biologics, sugars, proteins, nucleic acids and pharmaceuticals for use in biology for medical or veterinary use, namely for the diagnosis of ophthalmic conditions, or, for the treatment of ophthalmic conditions; Therapeutic biological products, namely, biologics, antibodies, monoclonal antibodies, cells and cellular tissues for medical use, namely for the treatment of ophthalmic conditions; Medical preparations for the treatment of ophthalmic conditions; Substances for use in genetic probe assay kits for medical use, namely, medical diagnostic reagents and assays for testing body fluids; Substances for veterinary use produced by genetic engineering, namely, genetically engineered tissues for transplant purposes; Cultures of cell media for medical use; Cultures of cell media for veterinary purposes; Chemical products for medical or veterinary laboratory use, namely, biologics, sugars, proteins, nucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditions, or, for the treatment of ophthalmic conditions; Chemical preparations for medical analysis purposes, namely, biologics, sugars, proteins, nucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditions; Chemical preparations for medical purposes for the diagnosis of ophthalmic conditions, or, for the treatment of ophthalmic conditions; Chemical preparations for veterinary purposes, namely, biologics, sugars, proteins, nucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditions, or, for the treatment of ophthalmic conditions; Chemical products for analysis for medical purposes, namely, biologics, sugars, proteins, nucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditions; Chemical products for analysis for veterinary purposes, namely, biologics, sugars, proteins, nucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditions; Chemical products for biotechnological purposes for medical uses, namely, biologics, sugars, proteins, nucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditions, or, for the treatment of ophthalmic conditions; Chemical products for biotechnological purposes for veterinary use, namely, biologics, sugars, proteins, nucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditions, or, for the treatment of ophthalmic conditions; Chemical products for medical or veterinary diagnostic purposes, namely, biologics, sugars, proteins, nucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditions; Chemical products for medical diagnostic use, namely, biologics, sugars, proteins, nucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditions; Chemical products for veterinary diagnostic use, namely, biologics, sugars, proteins, nucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditions; Chemical products for medical use, namely, biologics, sugars, proteins, nucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditions, or, for the treatment of ophthalmic conditions; Chemical products for use in medical science, namely, biologics, sugars, proteins, nucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditions, or, for the treatment of ophthalmic conditions; Chemical products for use in science for medical or veterinary purposes, namely, biologics, sugars, proteins, nucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditions, or, for the treatment of ophthalmic conditions; Chemicals for use in medical and veterinary analysis , namely, biologics, sugars, proteins, nucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditions
Goods and Services
Advisory services relating to scientific research; Laboratory services, namely, scientific research or analysis in the field of ophthalmology; Management of scientific research projects; Medical research and scientific research for medical purposes; Preparation of reports relating to scientific research; Preparation of scientific reports; Providing information, including online, about scientific and technological services and research and design relating thereto, namely for scientific research, analyses and testing in the field of ophthalmology; Provision of information relating to scientific research; Provision of scientific information in the field of ophthalmology; Scientific advisory services in the field of ophthalmology; Scientific analysis in the field of ophthalmology; Technical analysis for research and testing in the field of ophthalmology; Scientific and technological services namely for scientific research, analysis and testing in the field of ophthalmology; Scientific consultancy relating to ophthalmic conditions; Scientific laboratory services; Scientific research; Scientific research in the field of pharmacy; Scientific research into the development of new products; Scientific research relating to bacteriology; Scientific research relating to biology; Scientific research relating to chemical products; Scientific research relating to chemistry; Scientific research relating to genetics; Scientific testing services in the field of ophthalmology; Bacteriological research; Biochemistry research services; Biological research; Biotechnological research; Biotechnology research; Chemical research; Chemical technological research; Genetic research; Laboratory research; Medical research; Pharmaceutical research services; Providing information, including online, about industrial analysis and research services namely for scientific research, analyses and testing in the field of ophthalmology; Provision of medical, veterinary, biological and pharmaceutical research services in the field of ophthalmology; Research and development of new products for others; Research and development of products; Research into the development of new products; Research laboratories in the field of ophthalmology; Research relating to bacteriology; Research relating to biotechnology; Research relating to chemicals; Research relating to chemistry; Research relating to medicine; Research relating to molecular sciences; Research relating to pharmaceuticals; Research relating to science; Research to develop new products; Services for assessing the efficiency of pharmaceuticals namely pharmaceutical product evaluation; Services for assessing the safety of pharmaceuticals, namely testing, inspection or research of pharmaceuticals; Chemical analysis; Laboratory analysis in the field of ophthalmology; Analysis of tissues for medical research; Design of medical apparatus; Medical laboratory services; Analytical laboratory services, namely analysis of tissue samples or bodily fluids for diagnostic purposes; Chemical laboratory services; Laboratory testing services, namely testing of tissue samples or bodily fluids for diagnostic purposes; Veterinary laboratory services; Information in the field of chemical research; Testing of chemicals
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2017-06-23
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2017-06-23
Primary Code
042
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Keith A. Weltsch
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1350992
International Registration Date
2016-12-07
International Publication Date
2017-06-22
International Renewal Date
2026-12-07
Auto Protection Date
2018-12-22
International Status
001 - Request for extension of protection established
International Status Date
2017-06-22
Priority Claimed In
True
Priority Claimed Date
2016-06-08
First Refusal In
True
Trademark Events
Event DateEvent Description
2017-06-22SN ASSIGNED FOR SECT 66A APPL FROM IB
2017-06-23NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2017-06-23ASSIGNED TO EXAMINER
2017-06-27APPLICATION FILING RECEIPT MAILED
2017-06-29NON-FINAL ACTION WRITTEN
2017-06-30NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
2017-07-06REFUSAL PROCESSED BY MPU
2017-07-06NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
2017-07-28REFUSAL PROCESSED BY IB
2018-01-08TEAS RESPONSE TO OFFICE ACTION RECEIVED
2018-01-08CORRESPONDENCE RECEIVED IN LAW OFFICE
2018-01-09TEAS/EMAIL CORRESPONDENCE ENTERED
2018-02-06APPROVED FOR PUB - PRINCIPAL REGISTER
2018-02-21NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
2018-02-21NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2018-02-21NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
2018-03-09NOTIFICATION PROCESSED BY IB
2018-03-13PUBLISHED FOR OPPOSITION
2018-03-13OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2018-05-29REGISTERED-PRINCIPAL REGISTER
2018-08-29FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
2018-09-12FINAL DISPOSITION PROCESSED
2018-09-12FINAL DISPOSITION NOTICE SENT TO IB
2018-09-28FINAL DECISION TRANSACTION PROCESSED BY IB
2021-01-02NEW REPRESENTATIVE AT IB RECEIVED